Ren Rong, Zhuang Li-Xing
Department of Rehabilitation, Shenzhen Futian Hospital of Chinese Medicine, Shenzhen 510405, China.
Zhen Ci Yan Jiu. 2009 Aug;34(4):262-6.
To observe the therapeutic effect of electroacupuncture plus moxibustion (EA-Moxi) of combined Shu- and Mu-acupoints on the symptoms and quality of daily life in chronic superficial gastritis (CSG) patients.
Sixty cases were randomly divided into EA-Moxi group (n = 30) and medication group (n = 30). For patients of the former group, EA (50 Hz, 3 mA) was applied to Zhongwan (CV 12), bilateral Weishu (BL 21), bilateral Zusanli (ST 36), in combination with bilateral Ganshu (BL 18) and Qimen (LR 14) for patients with liver-stomach disharmony syndrome, and with moxibustion of Zhongwan (CV 12), bilateral Weishu (BL 21), bilateral Zusanli (ST 36), Pishu (BL 20) and Zhangmen (LR 13) for those with spleen-stomach deficiency syndrome. The treatment was administrated once a day, five days a week for 4 weeks. The patients of medication group were treated with Omeperazole (20 mg, qd.) capsules. The total course of treatment was 4 weeks. Clinical therapeutic effects were evaluated according to some related standards, and the quality of life was assessed by SF-36 questionnaire.
After the treatment, of the 30 cases in EA-Moxi and medication groups, 6 (20.0%) and 3 (10.0%) were cured, 16 (53.3%) and 8 (26.7%) experienced marked improvement, 5 (16.7%) and 9 (30.0%) were effective, and 3 (10.0%) and 10 (33.3%) failed, with the effective rates being 90.0% and 66.7% respectively. The difference of the effective rates between two groups was significant (P < 0.05). Self-comparison showed a marked improvement in the quality of life including physical function (PF), role physical (RP), bodily pain (BP), general health (GH), vitality (VT), social function (SF), role emotion (RE) and mental health (MH) in both groups after the treatment. The scores of health utility (HU), RP and RE in EA-Moxi group were evidently higher than those of medication group (P < 0.05, P < 0.01).
EA-Moxi of combined Shu- and Mu-acupoints can effectively relieve CSG patients' clinical symptoms and their quality of life.
观察电针加艾灸（电针 - 艾灸）联合俞募穴治疗慢性浅表性胃炎（CSG）患者症状及日常生活质量的疗效。
将60例患者随机分为电针 - 艾灸组（n = 30）和药物组（n = 30）。电针 - 艾灸组患者，中脘（CV 12）、双侧胃俞（BL 21）、双侧足三里（ST 36）接电针（50Hz，3mA），肝胃不和证患者加双侧肝俞（BL 18）和期门（LR 14），脾胃虚弱证患者加中脘（CV 12）、双侧胃俞（BL 21）、双侧足三里（ST 36）、脾俞（BL 20）和章门（LR 13）艾灸。治疗每日1次，每周5次，共4周。药物组患者口服奥美拉唑胶囊（20mg，qd.）。总疗程4周。根据相关标准评估临床疗效，采用SF - 36问卷评估生活质量。
治疗后，电针 - 艾灸组30例中，治愈6例（20.0%），显效16例（53.3%），有效5例（16.7%），无效3例（10.0%），有效率90.0%；药物组30例中，治愈3例（10.0%），显效8例（26.7%），有效9例（30.0%），无效10例（33.3%），有效率66.7%。两组有效率差异有统计学意义（P < 0.05）。自身比较显示，两组治疗后生活质量包括生理功能（PF）、生理职能（RP）、躯体疼痛（BP）、总体健康（GH）、活力（VT）、社会功能（SF）、情感职能（RE）和精神健康（MH）均有显著改善。电针 - 艾灸组健康效用（HU）、RP和RE评分明显高于药物组（P < 0.05，P < 0.01）。
俞募穴联合电针 - 艾灸能有效缓解CSG患者的临床症状，提高其生活质量。
